NCT05304468View on ClinicalTrials.gov

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

October 29, 2026

Study Completion Date

October 29, 2029

Conditions
Nasopharyngeal Carcinoma
Interventions
RADIATION

IMRT

Patients in experimental group received reduced dose IMRT

DRUG

induction chemotherapy

cisplatin-based induction chemotherapy for two cycles

DRUG

cisplatin concurrent chemotherapy

cisplatin 100mg/m2, for two(60Gy) or three cycles(70Gy)

Trial Locations (1)

510060

Sun Yat-sen Universitty Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER